PHI with Dementia in presenile sclerosis
How does this condition affect your private health insurance?
Demenz bei präseniler Sklerose refers to various forms of dementia with an onset typically before age 65, characterized by progressive cognitive decline. The "sclerosis" element may imply vascular changes or hardening of brain tissues. This umbrella term can encompass conditions like early-onset Alzheimer's disease, Frontotemporal Dementia, or vascular dementia, including specific types such as Binswanger's disease (subcortical arteriosclerotic encephalopathy). Symptoms include memory loss, language difficulties, behavioral changes, and impaired executive function, significantly impacting daily life. It is a progressive neurodegenerative disorder, distinct from age-related senile dementia due to its earlier onset.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms are often insidious, developing over several months to a year before clinical diagnosis.
Duration of Illness (Lifetime)
Chronic and progressive, typically lasting 5 to 15 years from diagnosis until death, depending on the specific underlying pathology and age of onset.
Cost of Treatment (Initial)
Initial diagnostic workup (neurological exam, MRI/CT scans, lab tests, cognitive assessments) can range from several hundreds to a few thousand USD/EUR.
Cost of Treatment (Lifetime)
Very high, often exceeding hundreds of thousands to over a million USD/EUR due to long-term medication, home care, assisted living, or nursing home facilities.
Mortality Rate
100% ultimately. It is a terminal illness, with death usually resulting from complications such as infections (e.g., pneumonia), malnutrition, or immobility.
Risk of Secondary Damages
Very high (>90%). This includes significant psychological distress for both the patient and caregivers, behavioral disturbances, loss of independence, increased risk of falls, infections, and complete functional decline.
Probability of Full Recovery
Extremely low (near 0%). Currently, there is no cure for neurodegenerative dementias; treatments focus on managing symptoms and slowing progression.
Underlying Disease Risk
High probability of associated vascular risk factors (e.g., hypertension, diabetes, hyperlipidemia) especially for vascular forms, or genetic predispositions for certain neurodegenerative subtypes.